Itraconazole for prophylaxis of systemic mycoses in neutropenic patients with haematological malignancies

Journal of Antimicrobial Chemotherapy

Volumn 38, Issue 6, 1996, Pages 953-961

  Bohme A ^a   Just Nubling G ^a   Bergmann, L ^a   Shah, P M ^a   Stille, W ^a   Hoelzer, D ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ITRACONAZOLE; VINCRISTINE;

ADULT; AGED; ARTICLE; CANDIDA; DRUG EFFICACY; FEMALE; GRANULOCYTOPENIA; HUMAN; LUNG ASPERGILLOSIS; MAJOR CLINICAL STUDY; MALE; MICROCAPSULE; MYCOSIS; NEUROTOXICITY; NEUTROPENIA; PROPHYLAXIS; TRICHOSPORON;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AGRANULOCYTOSIS; ANTIFUNGAL AGENTS; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; ITRACONAZOLE; MALE; MIDDLE AGED; MYCOSES; PROSPECTIVE STUDIES;

EID: 0030475787     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/38.6.953     Document Type: Article

References (35)

1. Aisner, J., Schimpff, S. C. & Wiernik, P. H. (1977). Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response. Annals of Internal Medicine 86, 539-43.
2. Beyer, J., Schwartz, S., Barzen, G., Risse, G., Dullenkopf, K., Weyer, C. et al. (1994). Use of amphotericin B aerosols for the prevention of pulmonary aspergillosis. Infection 22, 143-8.
3. Bodey, G., Bueltmann, B., Duguid, W., Gibbs, D., Hanak, H., Hotchi, M. et al. (1992). Fungal infections in cancer patients: an international autopsy survey. European Journal of Clinical Microbiology and Infectious Diseases 11, 99-109.
4. Bodey, G. P. & Vartivarian, S. (1989). Aspergillosis. European Journal of Clinical Microbiology and Infectious Diseases 8, 413-37.
5. Böhme, A., Ganser, A. & Hoelzer, D. (1995). Aggravation of vincristine-induced neurotoxicity by itraconazole in the treatment of adult ALL. Annals of Hematology 71, 311-2.
6. Böhme, A., Just, G., Bergmann, L., Shah, P. M., Hoelzer, D. & Stille, W. (1994). Itraconazole as antifungal prophylaxis for neutropenic patients with hematologic malignancies. Onkologie 17, Suppl 2, 13.
7. Boogaerts, M. A., Verhoef, G. E., Zachee, P., Demuynck, H., Verbist, L. & De Beule, K. (1989). Antifungal prophylaxis with itraconazole in prolonged neutropenia: correlation with plasma levels. Mycoses 32, Suppl. 1, 103-8.
8. Burch, P. A., Karp, J. E., Merz, W. G., Kuhlman, J. E. & Fishman, E. K. (1987). Favorable outcome of invasive aspergillosis in patients with acute leukemia. Journal of Clinical Oncology 5, 1985-93.
9. Como, J. A. & Dismukes, W. E. (1994). Oral azole drugs as systemic antifungal therapy. New England Journal of Medicine 330, 263-72.
10. De Beule, K., De Doncker, P., Cauwenbergh, G., Koster, M., Legendre, R., Blatchford, N. et al. (1988). The treatment of aspergillosis and aspergilloma with itraconazole, clinical results of an open international study (1982-1987). Mycoses 31, 476-85.
11. Denning, D. W., Tucker, R. M., Hanson, L. H. & Stevens, D. A. (1990). Itraconazole in opportunistic mycoses: cryptococcosis and aspergillosis. Journal of the American Academy of Dermatology 23, 602-7.
12. Gerson, S. L., Talbot, G. H., Hurwitz, S., Strom, B. L., Lusk, E. J. & Cassileth, P. A. (1984). Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Annals of Internal Medicine 100, 345-51.
13. Gupta, S., Kim, J. & Gollapudi, S. (1991). Reversal of daunorubicin resistance in P388/ADR cells by itraconazole. Journal of Clinical Investigation 87, 1467-9.
14. Hertenstein, B., Kern, W. V., Schmeiser, T., Stefanic, M., Bunjes, D., Wiesneth, M. et al. (1994). Low incidence of invasive fungal infections after bone marrow transplantation in patients receiving amphotericin B inhalations during neutropenia. Annals of Hematology 68, 21-6.
15. Kuhlman, J. E., Fishman, E. K., Burch, P. A., Karp, J. E., Zerhouni, E. A. & Siegelman, S. S. (1987). Invasive pulmonary aspergillosis in acute leukemia. The contribution of CT to early diagnosis and aggressive management. Chest 92, 95-9.
16. Meyers, J. D. (1990). Fungal infections in bone marrow transplant patients. Seminars in Oncology 17, Suppl. 6, 10-3.
17. Mühldorfer, S. M. & König, H. J. (1990). Prophylaxis of fungal infections with itraconazole in immunocompromised cancer patients. Mycoses 33, 291-5.
18. Orr, D. P., Myerowitz, R. L. & Dubois, P. J. (1978). Patho-radiologic correlation of invasive pulmonary aspergillosis in the compromised host. Cancer 41, 2028-39.
19. Pannuti, C. S., Gingrich, R. D., Pfaller, M. A. & Wenzel, R. P. (1991). Nosocomial pneumonia in adult patients undergoing bone marrow transplantation: a 9 year study. Journal of Clinical Oncology 9, 77-84.
20. Perraud, M., Piens, M. A., Nicoloyannis, N., Girard, P., Sepetjan, M. & Garin, J. P. (1987). Invasive nosocomial pulmonary aspergillosis: risk factors and hospital building works. Epidemiology and Infection 99, 407-12.
21. Rinaldi, M. G. (1991). Problems in the diagnosis of invasive fungal diseases. Reviews of Infectious Diseases 13, 493-5.
22. Robertson, M. J. & Larson, R. A. (1988). Recurrent fungal pneumonias in patients with acute nonlymphocytic leukemia undergoing multiple courses of intensive chemotherapy. American Journal of Medicine 84, 233-9.
23. Roos, N., Fahrenkamp, A., von Eiff, M., Diederich, S., Bömmelburg, T., Ritter, J. et al. (1991). Diagnostic value of radiologic imaging methods in detection and follow-up of invasive pulmonary aspergillosis. Mycoses 34, Suppl. 1, 37-41.
24. Rüchel, R. (1993). Diagnosis of invasive mycoses in severely immunosuppressed patients. Annals of Hematology 67, 1-11.
25. Saral, R. (1991). Candida and aspergillus in immunocompromised patients: an overview. Reviews of Infectious Diseases 13, 487-92.
26. Thunnissen, P. L. M., Sizoo, W. & Hendriks, W. D. H. (1991). Safety and efficacy of itraconazole in prevention of fungal infections in neutropenic patients. Netherlands Journal of Medicine 39, 84-91.
27. Tricot, G., Joosten, E., Boogaerts, M. A., Vande Pitte, J. & Cauwenbergh, G. (1987). Ketoconazole vs. itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies. Reviews of Infectious Diseases 9, Suppl. 1, 94-9.
28. Vanden Bossche, H., Bellens, D., Cools, W., Gorrens, J., Marichal, P., Verhoeven, H. et al. (1986). Cytochrome P-450: target for itraconazole. Drug Development Research 8, 287-98.
29. van't Wout, J. W., Novakova, I., Verhagen, C. A. H., Fibbe, W. E., de Pauw, B. E. & van der Meer, J. W. M. (1991). The efficacy of itraconazole against systemic fungal infections in neutropenic patients: a randomised comparative study with amphotericin B. Journal of Infection 22, 45-52.
30. Vreugdenhil, G., Raemaekers, J. M. M., van Dijke, B. J. & de Pauw, B. E. (1993). Itraconazole and multidrug resistance: possible effects on remission rate and disease-free survival in acute leukemia. Annals of Hematology 67, 107-9.
31. Vreugdenhil, G., Ven Dijke, B. J., Donnelly, J. P., Novakova, I. R. O., Raemaekers, J. M. M., Hoogkamp-Korstanje, M. A. A. et al. (1993). Efficacy of itraconazole in the prevention of fungal infections among neutropenic patients with hematologic malignancies and intensive chemotherapy. A double-blind, placebo controlled study. Leukemia and Lymphoma 11, 353-8.
32. Walsh, T. J. (1990). Invasive aspergillosis in patients with neoplastic diseases. Seminars in Respirator Infections 5, 111-22.
33. Weber, S. F., Peacock. J. E., Do, K. A., Cruz, J. M., Powell, B. L. & Capizzi, R. L. (1990). Interaction of granulocytopenia and construction activity as risk factors for nosocomial invasive filamentous fungal disease in patients with hematologic disorders. Infection Control and Hospital Epidemiology 11, 235-42.
34. Woestenborghs, R., Lorreyne, W. & Heykants, J. (1987). Determination of itraconazole in plasma and animal tissues by high-performance liquid chromatography. Journal of Chromatography 413, 332-7.
35. Zhou-Pan, X.-R., Seree, E., Zhou, X-J., Placidi, M., Maurel, P., Barra, Y. et al. (1993). Involvement of human liver cytochrome P 450 3A in vinblastine metabolism: drug interaction. Cancer Research 53, 5121-6.